EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Antipsychotic management in general practice: serial cross-sectional study (2011–2020)

Alan Woodall iD, Alex Gampel iD, Lauren E Walker iD, Frances S Mair iD, Sally Sheard iD, Pyers Symon iD, Iain Buchan iD

British Journal of General Practice · 2025-01 · 75 (750) · e68-e79

DOI: 10.3399/bjgp.2024.0367 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift British Journal of General Practice, online erschienen am 20.09.2024. Verfasst von Alan Woodall und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Primary Care and Mental Health, Institute of Population Health, University of Liverpool, Liverpool; clinical lead for integrated care, …. Hauptthemen laut MEDLINE: Antipsychotic Agents, General Practice, Practice Patterns, Physicians'. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Long-term use of antipsychotics confers increased risk of cardiometabolic disease. Ongoing need should be reviewed regularly by psychiatrists.

Aim

To explore trends in antipsychotic management in general practice, and the proportions of patients prescribed antipsychotics receiving psychiatrist review. Design and setting Serial cross-sectional study using linked general practice and hospital data in Wales (2011–2020).

Method

Participants were adults (aged ≥18 years) registered with general practices in Wales. Outcome measures were prevalence of patients receiving ≥6 antipsychotic prescriptions annually, the proportion of patients prescribed antipsychotics receiving annual psychiatrist review, and the proportion of patients prescribed antipsychotics who were registered on the UK serious mental illness, depression, and/or dementia registers, or not on any of these registers.

Results

Prevalence of adults prescribed long-term antipsychotics increased from 1.055% (95% confidence interval [CI] = 1.041 to 1.069) in 2011 to 1.448% (95% CI = 1.432 to 1.464) in 2020. The proportion receiving annual psychiatrist review decreased from 59.6% (95% CI = 58.9 to 60.4) in 2011 to 52.0% (95% CI = 51.4 to 52.7) in 2020. The proportion of overall antipsychotic use prescribed to patients on the serious mental illness register decreased from 50.0% (95% CI = 49.4 to 50.7) in 2011 to 43.6% (95% CI = 43.0 to 44.1) by 2020.

Conclusion

Prevalence of long-term antipsychotic use is increasing. More patients are managed by GPs without psychiatrist review and are not on monitored disease registers; they thus may be less likely to undergo cardiometabolic monitoring and miss opportunities to optimise or deprescribe antipsychotics. These trends pose risks for patients and need to be addressed urgently.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antipsychotic AgentsGeneral PracticePractice Patterns, Physicians'HumansCross-Sectional StudiesFemaleMaleMiddle AgedWalesAdultAgedMental Disorders

Stichwörter der Autor:innen

antipsychoticscardiometabolic risk factorscross-sectional studiesgeneral practicemedication reviewpsychiatry

Substanzen

Antipsychotic Agents

Autor:innen und Institutionen

  • Department of Primary Care and Mental Health, Institute of Population Health, University of Liverpool, Liverpool; clinical lead for integrated care, Powys Teaching Health Board, Bronllys, Powys.
  • Powys Teaching Health Board, Bronllys, Powys.
  • Centre for Experimental Therapeutics, University of Liverpool, Liverpool.
  • General Practice and Primary Care, School of Health and Wellbeing, University of Glasgow, Glasgow.
  • Department of Public Health, Policy and Systems, Institute of Population Health, University of Liverpool, Liverpool.
  • National Institute for Health and Care Research (NIHR) Mental Health Research for Innovation Centre, University of Liverpool, Liverpool.

ORCID-Profile: Alan Woodall, Alex Gampel, Lauren E Walker, Frances S Mair, Sally Sheard, Pyers Symon, Iain Buchan

Zitieren

APA

Woodall, A., Gampel, A., Walker, L. E., Mair, F. S., Sheard, S., Symon, P., & Buchan, I. (2025). Antipsychotic management in general practice: serial cross-sectional study (2011–2020). British Journal of General Practice, 75(750), e68-e79. https://doi.org/10.3399/bjgp.2024.0367

Vancouver

Woodall A, Gampel A, Walker LE, Mair FS, Sheard S, Symon P, et al. Antipsychotic management in general practice: serial cross-sectional study (2011–2020). British Journal of General Practice. 2025;75(750):e68-e79. doi:10.3399/bjgp.2024.0367

BibTeX
@article{Woodall2025,
  author = {Woodall, Alan and Gampel, Alex and Walker, Lauren E and Mair, Frances S and Sheard, Sally and Symon, Pyers and Buchan, Iain},
  title = {Antipsychotic management in general practice: serial cross-sectional study (2011–2020)},
  journal = {British Journal of General Practice},
  year = {2025},
  volume = {75},
  number = {750},
  pages = {e68--e79},
  doi = {10.3399/bjgp.2024.0367}
}
Kostenlos starten →